Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Design|September 11, 2008
The endocannabinoid system in amyotrophic lateral sclerosisLynsey G Bilsland, Linda GreensmithCurrent Opinion in Cell Biology|May 23, 2008
Molecular landmarks along the axonal route: axonal transport in health and diseaseSara Salinas, Lynsey G Bilsland, Giampietro SchiavoJournal of Neurochemistry|September 24, 2008
Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondriaLynsey G Bilsland, Niranjanan Nirmalananthan, Jing Yip, et al.Proceedings of the National Academy of Sciences of the United States of America|November 10, 2010
Deficits in axonal transport precede ALS symptoms in vivoLynsey G Bilsland, Erik Sahai, Gavin Kelly, et al.Plos Pathogens|May 23, 2009
CAR-associated vesicular transport of an adenovirus in motor neuron axonsSara Salinas, Lynsey G Bilsland, Daniel Henaff, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2006
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 miceLynsey G Bilsland, James R T Dick, Gareth Pryce, et al.Human Molecular Genetics|February 15, 2011
Absence of disturbed axonal transport in spinal and bulbar muscular atrophyBilal Malik, Niranjanan Nirmalananthan, Lynsey G Bilsland, et al.Nature Medicine|March 16, 2005
Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS modelG Scott Ralph, Pippa A Radcliffe, Denise M Day, et al.Pageof 1